#pharmanews — Public Fediverse posts

DATE: August 31, 2026 at 11:13AM
SOURCE: PSYCHIATRIC TIMES

Direct article link at end of text block below.

As August comes to a close, be sure to check out all the updates on psychopharmacology from this month: https://t.co/AqxtcD2JgL

Here are any URLs found in the article text:

https://t.co/AqxtcD2JgL

Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org

-------------------------------------------------

#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #Psychopharmacology #AugustUpdates #PharmaNews #MentalHealthScience #ResearchNews

DATE: August 31, 2026 at 11:13AM
SOURCE: PSYCHIATRIC TIMES

Direct article link at end of text block below.

As August comes to a close, be sure to check out all the updates on psychopharmacology from this month: https://t.co/AqxtcD2JgL

Here are any URLs found in the article text:

https://t.co/AqxtcD2JgL

Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org

-------------------------------------------------

#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #Psychopharmacology #AugustUpdates #PharmaNews #MentalHealthScience #ResearchNews

DATE: August 31, 2026 at 11:13AM
SOURCE: PSYCHIATRIC TIMES

Direct article link at end of text block below.

As August comes to a close, be sure to check out all the updates on psychopharmacology from this month: https://t.co/AqxtcD2JgL

Here are any URLs found in the article text:

https://t.co/AqxtcD2JgL

Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org

-------------------------------------------------

#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #Psychopharmacology #AugustUpdates #PharmaNews #MentalHealthScience #ResearchNews

https://www.europesays.com/ch/89238/ FDA clears Novartis’ oral drug for chronic hives #ChronicSpontaneousUrticaria #ImmunologyAndInflammation #Novartis #PharmaNews #RegulatoryApproval #remibrutinib #Rhapsido®

Torrent Pharma Q4 Profit Declines Amid Acquisition Expenditure

Torrent Pharma's Q4 net profit fell 26% due to costs from buying JB Pharma and severance payments. Learn how this affects the company.

#TorrentPharma, #JBPharma, #Q4Results, #AcquisitionCosts, #PharmaNews

https://newsletter.tf/torrent-pharma-q4-profit-drops-due-to-acquisition-costs/

Torrent Pharma's Q4 profit dropped by 26%, a significant decrease compared to previous periods. This is mainly due to spending on the JB Pharma acquisition.

#TorrentPharma, #JBPharma, #Q4Results, #AcquisitionCosts, #PharmaNews
https://newsletter.tf/torrent-pharma-q4-profit-drops-due-to-acquisition-costs/

Sanofi Sees Mixed Signals Amidst Investment and Market Fluctuations

Sanofi invests $294M in Toronto AI center. See how this impacts their stock price and what analysts say about future performance.

#SanofiAI, #TorontoTech, #PharmaNews, #StockMarket, #Investment

https://newsletter.tf/sanofi-ai-investment-toronto-stock-fluctuates/

Sanofi Sees Mixed Signals Amidst Investment and Market Fluctuations

Sanofi invests $294M in Toronto AI center. See how this impacts their stock price and what analysts say about future performance.

#SanofiAI, #TorontoTech, #PharmaNews, #StockMarket, #Investment

https://newsletter.tf/sanofi-ai-investment-toronto-stock-fluctuates/

Sanofi Sees Mixed Signals Amidst Investment and Market Fluctuations

Sanofi invests $294M in Toronto AI center. See how this impacts their stock price and what analysts say about future performance.

#SanofiAI, #TorontoTech, #PharmaNews, #StockMarket, #Investment

https://newsletter.tf/sanofi-ai-investment-toronto-stock-fluctuates/

Sanofi is investing $294 million in its Toronto AI center. This shows a big focus on new technology for the company.

#SanofiAI, #TorontoTech, #PharmaNews, #StockMarket, #Investment
https://newsletter.tf/sanofi-ai-investment-toronto-stock-fluctuates/

Sanofi is investing $294 million in its Toronto AI center. This shows a big focus on new technology for the company.

#SanofiAI, #TorontoTech, #PharmaNews, #StockMarket, #Investment
https://newsletter.tf/sanofi-ai-investment-toronto-stock-fluctuates/

Sanofi is investing $294 million in its Toronto AI center. This shows a big focus on new technology for the company.

#SanofiAI, #TorontoTech, #PharmaNews, #StockMarket, #Investment
https://newsletter.tf/sanofi-ai-investment-toronto-stock-fluctuates/

ANTITRUST Biogen probed by Italy over MS drug competition cinquewnews.blogspot.com/2026/05/biog... #Antitrust #Biogen #MultipleSclerosis #MSDrug #PharmaNews #ItalianAntitrust #CompetitionLaw #HealthcareIndustry #Biotech #Natalizumab #Sandoz #DrugMarket #EUCompetition #Pharmaceuticals #MedicalNews

Biogen probed by Italy over MS...

ANTITRUST Biogen probed by Italy over MS drug competition cinquewnews.blogspot.com/2026/05/biog... #Antitrust #Biogen #MultipleSclerosis #MSDrug #PharmaNews #ItalianAntitrust #CompetitionLaw #HealthcareIndustry #Biotech #Natalizumab #Sandoz #DrugMarket #EUCompetition #Pharmaceuticals #MedicalNews

Biogen probed by Italy over MS...

ANTITRUST Biogen probed by Italy over MS drug competition cinquewnews.blogspot.com/2026/05/biog... #Antitrust #Biogen #MultipleSclerosis #MSDrug #PharmaNews #ItalianAntitrust #CompetitionLaw #HealthcareIndustry #Biotech #Natalizumab #Sandoz #DrugMarket #EUCompetition #Pharmaceuticals #MedicalNews

Biogen probed by Italy over MS...

ANTITRUST Biogen probed by Italy over MS drug competition cinquewnews.blogspot.com/2026/05/biog... #Antitrust #Biogen #MultipleSclerosis #MSDrug #PharmaNews #ItalianAntitrust #CompetitionLaw #HealthcareIndustry #Biotech #Natalizumab #Sandoz #DrugMarket #EUCompetition #Pharmaceuticals #MedicalNews

Biogen probed by Italy over MS...

ANTITRUST Biogen probed by Italy over MS drug competition cinquewnews.blogspot.com/2026/05/biog... #Antitrust #Biogen #MultipleSclerosis #MSDrug #PharmaNews #ItalianAntitrust #CompetitionLaw #HealthcareIndustry #Biotech #Natalizumab #Sandoz #DrugMarket #EUCompetition #Pharmaceuticals #MedicalNews

Biogen probed by Italy over MS...

Muck Rack Secures STAT Content Deal, Bolstering Health Sector Monitoring

Muck Rack now includes STAT's health and medicine news. This helps health companies track industry news more easily.

#MuckRack, #STATNews, #HealthTech, #Biotech, #PharmaNews

https://newsletter.tf/muck-rack-adds-stat-health-news/

Muck Rack Secures STAT Content Deal, Bolstering Health Sector Monitoring

Muck Rack now includes STAT's health and medicine news. This helps health companies track industry news more easily.

#MuckRack, #STATNews, #HealthTech, #Biotech, #PharmaNews

https://newsletter.tf/muck-rack-adds-stat-health-news/

Muck Rack Secures STAT Content Deal, Bolstering Health Sector Monitoring

Muck Rack now includes STAT's health and medicine news. This helps health companies track industry news more easily.

#MuckRack, #STATNews, #HealthTech, #Biotech, #PharmaNews

https://newsletter.tf/muck-rack-adds-stat-health-news/

Muck Rack Secures STAT Content Deal, Bolstering Health Sector Monitoring

Muck Rack now includes STAT's health and medicine news. This helps health companies track industry news more easily.

#MuckRack, #STATNews, #HealthTech, #Biotech, #PharmaNews

https://newsletter.tf/muck-rack-adds-stat-health-news/

Muck Rack, which tracks news from over 600,000 sources, has added STAT's health reporting. This gives users more access to important health industry news.

#MuckRack, #STATNews, #HealthTech, #Biotech, #PharmaNews
https://newsletter.tf/muck-rack-adds-stat-health-news/

Muck Rack, which tracks news from over 600,000 sources, has added STAT's health reporting. This gives users more access to important health industry news.

#MuckRack, #STATNews, #HealthTech, #Biotech, #PharmaNews
https://newsletter.tf/muck-rack-adds-stat-health-news/

Muck Rack, which tracks news from over 600,000 sources, has added STAT's health reporting. This gives users more access to important health industry news.

#MuckRack, #STATNews, #HealthTech, #Biotech, #PharmaNews
https://newsletter.tf/muck-rack-adds-stat-health-news/

Muck Rack, which tracks news from over 600,000 sources, has added STAT's health reporting. This gives users more access to important health industry news.

#MuckRack, #STATNews, #HealthTech, #Biotech, #PharmaNews
https://newsletter.tf/muck-rack-adds-stat-health-news/

Cipla Reports Mixed Fiscal Signals Amidst India Focus

Cipla's FY26 earnings calls reveal a strong focus on the Indian market. Find out what this means for investors and the company's future.

#Cipla #IndianMarket #EarningsCall #PharmaNews #FY26

https://newsletter.tf/cipla-fy26-earnings-calls-india-market-focus/

Cipla's earnings calls from July 2025 to April 2026 show a repeated focus on the Indian market, with calls covering Q1 FY26, Q4 FY25, and Q4 FY26.

#Cipla #IndianMarket #EarningsCall #PharmaNews #FY26
https://newsletter.tf/cipla-fy26-earnings-calls-india-market-focus/

https://www.europesays.com/dk/76609/ Novo sees comeback as weight-loss pill boom revives investor confidence – Firstpost #DenmarkPharma #EliLilly #Foundayo #GLP1Drugs #HealthcareStocks #NovoNordisk #NovoShares #ObesityDrugs #ObesityTreatmentMarket #ozempic #PeptideTherapies #PharmaNews #WegovyPill #WeightLossDrugCompetition #WeightLossPill

https://www.europesays.com/ch/60767/ Roche breaks ground on US manufacturing facility #Genentech #investment #Manufacturing #MetabolicDiseases #Obesity #PharmaNews #Roche #tariffs

Novo Nordisk Navigates Shifting Market Sands: Outlook Adjusted Amidst Competition and Transformation

Novo Nordisk expects sales and profits to fall 5-13% in 2026. This is due to lower prices, new competition for weight loss drugs, and company costs.

#NovoNordisk, #Ozempic, #Wegovy, #PharmaNews, #DrugCompetition

https://newsletter.tf/novo-nordisk-2026-sales-drop-competition/

Novo Nordisk's 2026 profit outlook is down 5-13%, a big change from its 2025 growth. This is because of lower drug prices and more companies selling similar weight loss medicines.

#NovoNordisk, #Ozempic, #Wegovy, #PharmaNews, #DrugCompetition
https://newsletter.tf/novo-nordisk-2026-sales-drop-competition/

https://www.europesays.com/dk/61985/ Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery #AIIntegration #AIIntegrationInHealth #ArtificialIntelligence #ChronicAilments #ChronicDisease #DiabetesResearch #DrugDiscovery #HealthAndAI #HealthcareInnovation #NovoNordisk #NovoNordiskDiabetesTreatment #NovoNordiskObesityDrugWegovy #NovoNordiskWeightLossDrig #OpenAI #PharmaNews #PharmaceuticalManufacturers #SamAltlam #SamAltmanAI

https://www.europesays.com/ie/411144/ Advances in Detection, Treatment & Control #AnalyticalMagazine #Éire #Health #IE #Ireland #LabEquipmentLaunch #LabEquipmentNews #LaboratoryMagazine #PharmaMagazine #PharmaNews

https://www.europesays.com/ie/411102/ The “Cicada” COVID Variant Explained #AnalyticalMagazine #Éire #Health #IE #Ireland #LabEquipmentLaunch #LabEquipmentNews #LaboratoryMagazine #PharmaMagazine #PharmaNews

https://www.europesays.com/at/56985/ Marinomed will mit Kapitalerhöhung Finanzlücke schließen #AT #Austria #Biotechnologie #BiotechnologieNews #BranchenNews #Business #ChemischeIndustrie #Companies #Companies&Markets #CorporatesNews #EuropaNews #KurzNews #Marinomed #Markets #Märkte #Österreich #PharmaNews #Unternehmen #Unternehmen&Märkte #WienAutorevue #WirtschaftOsterreichTrend #WirtschaftUndFinanzenNews #WissenupdateMeNews

https://www.europesays.com/dk/41146/ Novo Nordisk Foundation pledges €736m for European biotech #BioInnovationInstitute #biotech #funding #NovoNordisk #NovoNordiskFoundation #PharmaNews

https://www.europesays.com/ch/27872/ Novartis’ new drugs outweigh Entresto decline in Q3 #Entreso #financial #generics #m&a #Novartis #PharmaNews #Sales&Marketing

https://www.europesays.com/ch/27288/ Roche gets EU nod for kidney disease algorithm #algorithms #ArtificialIntelligence #ClinicalDecisionMaking #DigitalHealth #Klinrisk #PharmaNews #RegulatoryApproval #Roche

https://www.europesays.com/ch/26016/ FDA clears Roche, Lilly Alzheimer’s blood test #Alzheimer'sDisease #dementia #diagnosis #EliLilly #InVitroDiagnostics #PharmaNews #RegulatoryApproval #Roche

Trump Strikes Deals with Nine Drug Companies to Lower Prescription Prices

Nine drug companies agreed to lower prices on Dec 19, 2025, with a new website TrumpRx. Find out how this affects prescription costs for Americans.

#DrugPrices, #TrumpDeals, #HealthcareCosts, #PharmaNews, #USManufacturing

https://newsletter.tf/trump-drug-deals-december-19-2025-lower-prices-americans/

Trump Strikes Deals with Nine Drug Companies to Lower Prescription Prices

Nine drug companies agreed to lower prices on Dec 19, 2025, with a new website TrumpRx. Find out how this affects prescription costs for Americans.

#DrugPrices, #TrumpDeals, #HealthcareCosts, #PharmaNews, #USManufacturing

https://newsletter.tf/trump-drug-deals-december-19-2025-lower-prices-americans/

Nine drug companies agreed to lower prices on prescription drugs starting in January 2026. This is a change from previous pricing structures.

#DrugPrices, #TrumpDeals, #HealthcareCosts, #PharmaNews, #USManufacturing

https://newsletter.tf/trump-drug-deals-december-19-2025-lower-prices-americans/

Nine drug companies agreed to lower prices on prescription drugs starting in January 2026. This is a change from previous pricing structures.

#DrugPrices, #TrumpDeals, #HealthcareCosts, #PharmaNews, #USManufacturing

https://newsletter.tf/trump-drug-deals-december-19-2025-lower-prices-americans/

Big Pharma’s Hidden Power Shift: DHL Expands Global Drug Delivery Empire

Global logistics giant DHL is expanding its pharmaceutical airfreight network — and this isn’t just about faster shipping.

Behind the move is a trillion-dollar power play to control how medicines travel worldwide. From vaccines to biotech drugs, whoever dominates pharma logistics gains massive influence over global healthcare supply chains.

#DHL #pharmanews

ENTOD Pharmaceuticals Joins Global Efforts to Tackle Preventable Childhood Blindness

#TycoonWorld #ChildhoodBlindness #PreventableBlindness #RightToSight #EyeHealth #PaediatricOphthalmology #VisionCare #ROPPrevention #RetinopathyOfPrematurity #GlobalHealth #PublicHealth #SDG3 #HealthForAll #ChildHealth #HealthcareInnovation #PharmaNews #ENTODPharmaceuticals #Ophthalmology #EarlyScreening

https://tycoonworld.in/entod-pharmaceuticals-joins-global-efforts-to-tackle-preventable-childhood-blindness/

ENTOD Pharmaceuticals Joins Global Efforts to Tackle Preventable Childhood Blindness

#TycoonWorld #ChildhoodBlindness #PreventableBlindness #RightToSight #EyeHealth #PaediatricOphthalmology #VisionCare #ROPPrevention #RetinopathyOfPrematurity #GlobalHealth #PublicHealth #SDG3 #HealthForAll #ChildHealth #HealthcareInnovation #PharmaNews #ENTODPharmaceuticals #Ophthalmology #EarlyScreening

https://tycoonworld.in/entod-pharmaceuticals-joins-global-efforts-to-tackle-preventable-childhood-blindness/

ENTOD Pharmaceuticals Joins Global Efforts to Tackle Preventable Childhood Blindness

#TycoonWorld #ChildhoodBlindness #PreventableBlindness #RightToSight #EyeHealth #PaediatricOphthalmology #VisionCare #ROPPrevention #RetinopathyOfPrematurity #GlobalHealth #PublicHealth #SDG3 #HealthForAll #ChildHealth #HealthcareInnovation #PharmaNews #ENTODPharmaceuticals #Ophthalmology #EarlyScreening

https://tycoonworld.in/entod-pharmaceuticals-joins-global-efforts-to-tackle-preventable-childhood-blindness/

ENTOD Pharmaceuticals Joins Global Efforts to Tackle Preventable Childhood Blindness

#TycoonWorld #ChildhoodBlindness #PreventableBlindness #RightToSight #EyeHealth #PaediatricOphthalmology #VisionCare #ROPPrevention #RetinopathyOfPrematurity #GlobalHealth #PublicHealth #SDG3 #HealthForAll #ChildHealth #HealthcareInnovation #PharmaNews #ENTODPharmaceuticals #Ophthalmology #EarlyScreening

https://tycoonworld.in/entod-pharmaceuticals-joins-global-efforts-to-tackle-preventable-childhood-blindness/

ENTOD Pharmaceuticals Joins Global Efforts to Tackle Preventable Childhood Blindness

#TycoonWorld #ChildhoodBlindness #PreventableBlindness #RightToSight #EyeHealth #PaediatricOphthalmology #VisionCare #ROPPrevention #RetinopathyOfPrematurity #GlobalHealth #PublicHealth #SDG3 #HealthForAll #ChildHealth #HealthcareInnovation #PharmaNews #ENTODPharmaceuticals #Ophthalmology #EarlyScreening

https://tycoonworld.in/entod-pharmaceuticals-joins-global-efforts-to-tackle-preventable-childhood-blindness/

CDSCO flags 167 drug samples as Not of Standard Quality (NSQ) in December, including spurious drugs. Learn about the latest drug safety alerts and regulatory actions. https://english.mathrubhumi.com/news/india/cdsco-drug-quality-alert-december-h3iajdl6?utm_source=dlvr.it&utm_medium=mastodon #CDSCO #DrugSafety #NSQDrugs #MedicineQuality #PharmaNews

CDSCO flags 167 drug samples as Not of Standard Quality (NSQ) in December, including spurious drugs. Learn about the latest drug safety alerts and regulatory actions. https://english.mathrubhumi.com/news/india/cdsco-drug-quality-alert-december-h3iajdl6?utm_source=dlvr.it&utm_medium=mastodon #CDSCO #DrugSafety #NSQDrugs #MedicineQuality #PharmaNews

CDSCO flags 167 drug samples as Not of Standard Quality (NSQ) in December, including spurious drugs. Learn about the latest drug safety alerts and regulatory actions. https://english.mathrubhumi.com/news/india/cdsco-drug-quality-alert-december-h3iajdl6?utm_source=dlvr.it&utm_medium=mastodon #CDSCO #DrugSafety #NSQDrugs #MedicineQuality #PharmaNews

New lawsuits claim Ozempic and other GLP-1 drugs may be linked to NAION-related vision loss. Patients allege unexpected blindness risks. Read More Here: https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/
#Ozempic #GLP1 #NAION #VisionLoss #DrugSafety #PharmaNews

https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/

New lawsuits claim Ozempic and other GLP-1 drugs may be linked to NAION-related vision loss. Patients allege unexpected blindness risks. Read More Here: https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/
#Ozempic #GLP1 #NAION #VisionLoss #DrugSafety #PharmaNews

https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/

New lawsuits claim Ozempic and other GLP-1 drugs may be linked to NAION-related vision loss. Patients allege unexpected blindness risks. Read More Here: https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/
#Ozempic #GLP1 #NAION #VisionLoss #DrugSafety #PharmaNews

https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/

New lawsuits claim Ozempic and other GLP-1 drugs may be linked to NAION-related vision loss. Patients allege unexpected blindness risks. Read More Here: https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/
#Ozempic #GLP1 #NAION #VisionLoss #DrugSafety #PharmaNews

https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/

New lawsuits claim Ozempic and other GLP-1 drugs may be linked to NAION-related vision loss. Patients allege unexpected blindness risks. Read More Here: https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/
#Ozempic #GLP1 #NAION #VisionLoss #DrugSafety #PharmaNews

https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/

https://www.europesays.com/ie/281365/ FDA turns down Hetlioz for jet lag once again #Éire #fda #Health #HETLIOZ #IE #Ireland #jetlag #Medication #PharmaNews #Regulatory #SleepDisorders #VandaPharmaceuticals

Contamination Control in Cell Culture: A Technology-Driven Approach https://www.byteseu.com/1692303/ #AnalyticalMagazine #LabEquipmentLaunch #LabEquipmentNews #LaboratoryMagazine #PharmaMagazine #PharmaNews #Technology

The Science Behind Sperm Races https://www.byteseu.com/1337984/ #AnalyticalMagazine #LabEquipmentLaunch #LabEquipmentNews #LaboratoryMagazine #PharmaMagazine #PharmaNews #Science